The postgraduate courses offered at the ATS International Conference in San Francisco, California, will give you additional education through a convenient weekend schedule, May 13 and 14. Because the courses will fill up, you’ll want to register soon.
You have two options to register for the May 13 and 14 courses:
- Complement your learning by adding postgraduate courses to a full conference registration.
- Register only to attend postgraduate courses.
Whether you’re new or advanced in your field of clinical care or research, the courses benefit learners with varying levels of scientific and clinical experience. You’ll sharpen your diagnostic skills and learn about the latest research discoveries.
Postgraduate courses require an additional fee separate from general registration. Attendance is limited and available on a first-come, first-served basis. The following postgraduate courses are still available:
Postgraduate Courses
Friday, May 13
8 a.m.-4 p.m.
- PG1: State of the Art Course On Pleural Diseases: A Case-Based Approach
- PG2: Critical Care Ultrasound and Echocardiography Part I & II
- PG3: Genetic Pulmonary Medicine
- PG4: Palliative Care in the ICU: Clinical, Ethical, and Research Challenges
- PG5: Thoracic Imaging for the Pulmonologist and Critical Care Physician
- PG6: Interstitial Lung Disease: The Latest on Diagnosis and Management
- PG8: Critical Care Medicine for Advanced Practice Providers (NP/PA)
- PG9: The Physiology of Pediatric Respiratory Failure
- PG10: Airway Remodeling in Human Lung Disease: A Big Lab Meeting 2016
- PG11: Testing in the Pulmonary Function Lab: From Physiology to Clinical Practice
- PG12: Sleep and Critical Illness: Bridging the Two Pillars!
- PG13: Implementation of Core Components of a Lung Cancer Screening Program
- PG14: Pulmonary and Critical Care Reviews: Built Around the 2015 ABIM-SEP Modules
State of the Art Course On Pleural Diseases: A Case-Based Approach (PG1) is supported by an educational grant from Olympus Corporation of the Americas. The course also received in-kind support from BD, Cook Medical, LLC, Centurion Medical Products, FUJIFILM Sonosite, Inc., and Olympus Corporation of the Americas.
Critical Care Ultrasound and Echocardiography Part I & II (PG2) is supported in-kind by CAE Healthcare, FUJIFILM Sonosite, Inc., GE Healthcare, Teleflex, and Terason.
Genetic Pulmonary Medicine (PG3) is supported by educational grants from Actelion Pharmaceuticals US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Genentech, Pfizer Inc., United Therapeutics Corporation, and Vertex Pharmaceuticals, Inc.
Thoracic Imaging for the Pulmonologist and Critical Care Physician (PG5) is supported by educational grants from Actelion Pharmaceuticals US, Inc., AstraZeneca LP, and United Therapeutics Corporation.
Interstitial Lung Disease: The Latest on Diagnosis and Management (PG6) is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.
Implementation of Core Components of a Lung Cancer Screening Program (PG13) is supported by educational grants from AstraZeneca LP and Pfizer Inc.
Saturday, May 14
8 a.m.-4 p.m.
- PG15: Bronchoscopy Course and Workshop
- PG16: Heterogeneity and Plasticity of Lung Macrophages: Towards Precision Medicine
- PG17: Scientific Writing: Publishing for Academic Success
- PG18: NTM Lung Disease: Improve Your Practice/Debunk the Myths
- PG19: COPD: A Dynamic and Evolving Disease
- PG21: Epigenetics of Lung Disease
- PG22: Difficult Clinical Problems in Pulmonary and Critical Care Infections
- PG23: Diagnostic Tests in Pediatric Pulmonology: Indications and Interpretations
- PG24: Critical Care of the Patient With Pulmonary Vascular Disease
- PG25: Master Physiology Class: Core Principles of Respiratory Physiology
- PG26: Central Apneas, Cheyne-Stokes, and Periodic Breathing: New Insights and Their Impact on Daily Practice
- PG27: Lung Cancer: State of the Art in 2016
- PG28: Conflict Resolution in Critical Care: A Skills Course
Bronchoscopy Course and Workshop (PG15) is supported by educational grants from AstraZeneca LP, Boston Scientific Corporation, Inc., and Olympus Corporation of the Americas. The course also received in-kind support from Boston Scientific Corporation, Inc., CONMED, Cook Medical, LLC, ERBE USA, Inc., Medtronic, Minimally Invasive Therapies Group, Olympus Corporation of the Americas, Smiths Medical, and Veran Medical Technologies.
Heterogeneity and Plasticity of Lung Macrophages: Toward Precision Medicine (PG16) is supported by an educational grant from AstraZeneca LP.
NTM Lung Disease: Improve Your Practice/Debunk the Myths (PG18) is supported by an educational grant from Insmed Incorporated.
COPD: A Dynamic and Evolving Disease (PG19) is supported by educational grants from AstraZeneca LP and GlaxoSmithKline.
Critical Care of the Patient With Pulmonary Vascular Disease (PG24) is supported by educational grants from Actelion Pharmaceuticals US, Inc., and United Therapeutics Corporation.
Lung Cancer: State of the Art in 2016 (PG27) is supported by educational grants from AstraZeneca LP, Boston Scientific Corporation, Inc., and Pfizer Inc.